performance enhancing drugs
Recently Published Documents


TOTAL DOCUMENTS

280
(FIVE YEARS 70)

H-INDEX

23
(FIVE YEARS 3)

Author(s):  
C. James Watson ◽  
Genevra L. Stone ◽  
Daniel L. Overbeek ◽  
Takuyo Chiba ◽  
Michele M. Burns

Author(s):  
Samuel Iff ◽  
Ingo Butzke ◽  
Boris B Quednow ◽  
Rahul Gupta ◽  
Christian Imboden ◽  
...  

Author(s):  
Samuel Iff ◽  
Ingo Butzke ◽  
Boris B Quednow ◽  
Rahul Gupta ◽  
Christian Imboden ◽  
...  

2021 ◽  
Vol 3 ◽  
Author(s):  
Barend J. M. Steyn ◽  
Kim Nolte

The concept of ego has various meanings in the field of psychology, depending on the paradigmatic and theoretical framework point of departure. The ego phenomenon as operationalized and measured in the theoretical framework of goal orientation will be the contextual framework for a historical conceptual analysis. In the past three decades, research in the theoretical framework of goal orientation has revealed a positive relationship between ego involvement and the tendency to use the prohibited substances to enhance performance in sport. The concept of the ego phenomenon as operationalized within goal orientation theory and meanings attached to the concept can be connected to the historic oriental writings that were written ~2,500 years ago. These attached meanings to the ego phenomenon include elements of extreme competitiveness and outcome orientation, as well as social comparisons and the external norms for the measurement of success and failure. These meanings can be traced back to the classical works involving the Bhagavad Gita, the Tao Te Ching, and the Eastern Origins of Mindfulness that are part of the broader Buddhist philosophical system. Meister Eckhart, a 12th century German theologian, in his significant contribution on the analysis of the having mode as opposed to the being mode also provides insight into the ego phenomenon that can explain why the ego phenomenon can be linked to some of the deeper psychological motives of using the prohibited substances. The researchers in psychology do not yet have a full understanding of why certain athletes dope or have a susceptibility to use the prohibited substances or performance enhancing drugs (PEDs) and thus the motivation for this historical conceptual analysis of the ego phenomenon. Therefore, this article aimed to deepen the understanding of psychological motives of the athletes who exhibit tendencies toward cheating in general and the proclivity to use the prohibited substances.


2021 ◽  
pp. 019372352110436
Author(s):  
Krystyna Gotberg ◽  
Jacquelyn D. Wiersma-Mosley

The purpose of this study was to examine violence against women (VAW) in the National Football League (NFL). Since Ray Rice assaulted his partner on video, VAW by NFL players has received more public attention. However, there is little empirical research that examines VAW in the NFL and player suspensions compared to other violations. Data come from a public list of 176 NFL players known to have violated NFL policies from 2010–2019. Four major types of violations were found: VAW included sexual assault, rape, and domestic violence; general violent behaviors included assault or battery; drug-related offenses included substance abuse, alcohol, driving under the influence (DUI's), illegal drugs, and performance-enhancing drugs (PEDs); and minor sports-related infractions included issues such as missing a team meeting. The average number of game suspensions was 4.08 for VAW offenses, 1.75 for general violent offenses, 4.05 for drug-related offenses and 1.88 for minor infractions. We found no differences in the number of game suspensions for drug-related offenses compared to VAW; general violent offenses had even fewer suspensions. These numbers are contradictory to the NFL's Personal Conduct Policy of a 6-game suspension without pay for VAW and general violence.


2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Jim McVeigh ◽  
Evelyn Hearne ◽  
Ian Boardley ◽  
Geoff Bates ◽  
Vivian Hope ◽  
...  

Abstract Background The use of anabolic androgenic steroids (AAS) and associated image and performance enhancing drugs (IPEDs) is now a global phenomenon. There is a need to develop evidence to support the development of interventions to prevent the commencement of use, to minimise the potential harms or to support those in their cessation of use. While the United Kingdom (UK) is no exception to this issue, its public health and legislative response to the phenomenon differs to other countries and requires the examination of research specific to the UK. Therefore, a scoping review has been conducted to examine the recent relevant literature to help inform the development and evaluation of effective interventions to reduce the harmful use of IPEDs. Methods A comprehensive search strategy was developed for multiple bibliographic databases, supported by and iterative citation searching process and complimented by expert input from the Anabolic Steroid UK Network. Research conducted by or UK academics or within the UK were eligible, if published in the previous five years. Results In total 87 eligible outputs were identified, including 26 review articles, 25 qualitative papers and 24 quantitative papers. together with small numbers of clinical studies/case reports (6) and commentaries/correspondence (6). The most common topics of research were public health, treatment and harm reduction (41), followed by studies focusing on epidemiology, sub-groups of people using IPEDs and motivations for use (34). The studies illustrated the diverse populations of people who use a range of enhancement drugs including concomitant psychoactive drug use. A number of papers focused on blood borne viruses and associated issues, while others reported on the uptake of needle and syringe programmes. No effectiveness evaluations related to any aspect of treatment, harm reduction or other intervention were published during study period. Conclusion There is a need for the development of effectiveness evaluations of current interventions and any future service provision for people using image and performance enhancing drugs. While there have been no studies of this nature to date, this review illustrates the rich data that has been gathered through diverse methodologies, that will assist in the development of future effectiveness evaluations.


Molecules ◽  
2021 ◽  
Vol 26 (20) ◽  
pp. 6210
Author(s):  
Marwa T. Badawy ◽  
Mansour Sobeh ◽  
Jianbo Xiao ◽  
Mohamed A. Farag

Androstenedione is a steroidal hormone produced in male and female gonads, as well as in the adrenal glands, and it is known for its key role in the production of estrogen and testosterone. Androstenedione is also sold as an oral supplement, that is being utilized to increase testosterone levels. Simply known as “andro” by athletes, it is commonly touted as a natural alternative to anabolic steroids. By boosting testosterone levels, it is thought to be an enhancer for athletic performance, build body muscles, reduce fats, increase energy, maintain healthy RBCs, and increase sexual performance. Nevertheless, several of these effects are not yet scientifically proven. Though commonly used as a supplement for body building, it is listed among performance-enhancing drugs (PEDs) which is banned by the World Anti-Doping Agency, as well as the International Olympic Committee. This review focuses on the action mechanism behind androstenedione’s health effects, and further side effects including clinical features, populations at risk, pharmacokinetics, metabolism, and toxicokinetics. A review of androstenedione regulation in drug doping is also presented.


2021 ◽  
Vol 12 ◽  
Author(s):  
Simona Zaami ◽  
Adele Minutillo ◽  
Ascanio Sirignano ◽  
Enrico Marinelli

Appearance- and performance-enhancing drugs (APEDs) are commonly used by adolescents and young adults in an effort to improve not only athletic performance but also physical and mental efficiency and sexual appearance. The rationale for using these drugs is grounded in the perceived importance of external appearance, the quest for health and youth, and the urge to boost one's sexual performances. Although APED users tend to be quite moderate overall, some specific subpopulations can display pathological use associated with high-risk behaviors. A wide and diverse range of APEDs is now easily accessible to almost anyone through backdoor online avenues. Common APEDs include anabolic–androgenic steroids, non-steroidal anabolics, anorectics, diuretics and ergo/thermogenics, nootropics or “cognition enhancers,” licit and illicit psychostimulants, and finally, sexual enhancers. The use of APEDs appears linked to several psychopathological disorders of unclear prevalence, e.g., body image disorders and eating disorders, perfectionism, but also depression and loneliness. The role of personality traits related to APED use has been investigated in adolescents and young adults, in elite and amateur athletes, and in chemsexers and associated with the above-reported personality traits. The studies herein analyzed show that APED consumption in the general population is quickly growing into a public health concern. It is therefore essential to launch prevention and intervention projects aimed at promoting safe instrumental use of the body, not only in sports disciplines but also among the general population, and to promote psychological aid procedures for people with substance use issues, depression and anxiety, and body image disorders.


Sign in / Sign up

Export Citation Format

Share Document